Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/2003
09/23/2003CA2101332C Antibody polycation conjugates
09/23/2003CA2100295C A psyllium-hydrocolloid gum composition
09/23/2003CA2074385C Pleuromutilin complexes
09/23/2003CA2072116C Shaped articles as obtained from a thermoplastic starch melt
09/20/2003CA2376356A1 Targeted ligands
09/18/2003WO2003076602A2 Use of l-$g(a)-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo
09/18/2003WO2003076594A2 Genomic screen for epigenetically silenced tumor suppressor genes
09/18/2003WO2003076565A2 Methods of using 46828, a human acyl-coa synthetase
09/18/2003WO2003076490A1 Hydrophilic polymer derivate with y type branch and preparation method of it medical composite comprising above compound
09/18/2003WO2003076475A1 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
09/18/2003WO2003076472A2 Neoplasm specific antibodies and uses thereof
09/18/2003WO2003075982A1 Multiple compartment bag assembly for dialysis fluid
09/18/2003WO2003075977A2 Agglomerated particles for aerosol drug delivery
09/18/2003WO2003075960A1 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
09/18/2003WO2003075957A1 The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
09/18/2003WO2003075956A2 Use of mixtures of lipopeptides for vaccine production
09/18/2003WO2003075942A1 Vitamin and zinc monomethionine compositions
09/18/2003WO2003075920A1 Eye drops containing tetrazole derivative
09/18/2003WO2003075909A1 Ibuprofen solution for hard shell capsules
09/18/2003WO2003075908A1 Use of adapalene for the treatment of dermatological disorders
09/18/2003WO2003075904A2 Cyclodextrin complexed artemisinins
09/18/2003WO2003075895A1 Tasted masked veterinary solid compositions
09/18/2003WO2003075893A1 Controlled release dosage forms
09/18/2003WO2003075892A1 Pharmaceutical microparticles
09/18/2003WO2003075891A1 Dispersed solid-containing complex carbohydrate
09/18/2003WO2003075890A1 Methods for entrapment of bioactive agent in a liposome or lipid complex
09/18/2003WO2003075889A1 An inhalation system for prevention and treatment of intracellular infections
09/18/2003WO2003075887A1 Sustained release drug formulations containing a carrier peptide
09/18/2003WO2003075885A1 Composition having gelling properties for the prolonged delivery of bioactive substances
09/18/2003WO2003075861A1 Antioxidative preparations
09/18/2003WO2003075855A2 Antibodies against cancer antigen tmeff2 and uses thereof
09/18/2003WO2003075847A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
09/18/2003WO2003075846A2 Uses of monoclonal antibody 8h9
09/18/2003WO2003075839A2 Methods of inducing terminal differentiation
09/18/2003WO2003075834A2 Activated protein c formulations
09/18/2003WO2003075826A2 Process for manufacturing pharmaceutical composition comprises of mycobacterium w in the treatment of asthma(obstructive lung disease)
09/18/2003WO2003075812A1 Controlled delivery patch of active ingredient
09/18/2003WO2003075741A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
09/18/2003WO2003075685A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
09/18/2003WO2003059973A3 Block copolymers
09/18/2003WO2003059296A3 Compositions comprising collagen and metalloprotease inhibitors
09/18/2003WO2003057163A3 Methods for preparing immunoconjugates
09/18/2003WO2003047521A3 Composition and method for treatment of otitis media
09/18/2003WO2003040093A3 Isotopically coded affinity marker 2
09/18/2003WO2003039595A3 Mucosal adjuvants comprising an oligonucleotide and a cationic lipid
09/18/2003WO2003035007A3 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
09/18/2003WO2003028600B1 Wipe formulation
09/18/2003WO2003005941A3 Insert for the treatment of dry eye
09/18/2003WO2002100901A3 Determination of bone-sialoprotein in bodily fluids for oncological problems
09/18/2003WO2002092136A3 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
09/18/2003WO2002053177A3 Agents and methods for treating pain
09/18/2003WO2002036110A9 Oral self-emulsifying formulations of pyranone protease inhibitors
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030176665 Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them
09/18/2003US20030176663 Specific binding molecules for scintigraphy
09/18/2003US20030176661 Novel antibody with specificity for colon cancer
09/18/2003US20030176638 Liquid phase complexing with a polymer
09/18/2003US20030176483 For therapy and prophylaxis of Herpes Simplex Virus and related diseases including secondary opportunist disease causing agents, while reducing the inflammation, prolonged healing times and reduce scaring
09/18/2003US20030176470 For prophylaxis and/or therapy of skin diseases and/ or inflammation responses of the skin
09/18/2003US20030176452 Oral absorption
09/18/2003US20030176448 Mitochondria protecting agents for treating mitochondria associated diseases
09/18/2003US20030176408 For topical application, penetration
09/18/2003US20030176399 Pharmaceutical formulations comprising indolinone derivatives
09/18/2003US20030176397 Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced GI toxicity
09/18/2003US20030176391 Oral fludara of high-purity formulation with quick release of active ingredient
09/18/2003US20030176389 Administering to a subject suffering from gastrointestinal inflammation a formulation comprising an immunomodulatory nucleic acid to the subject, the immunomodulatory nucleic acid comprising the sequence 5'-CpG-3'
09/18/2003US20030176381 Hyaluronic acid in the treatment of cancer
09/18/2003US20030176379 Useful in the administration of a drug, therapy
09/18/2003US20030176372 Anti-virus agent
09/18/2003US20030176369 Stabilized azithromycin compositions
09/18/2003US20030176359 Administration of a thiol-based chemoprotectant compound
09/18/2003US20030176345 Wound healing composition and method for use thereof
09/18/2003US20030176325 Modified peptide nucleic acid (PNA) molecules
09/18/2003US20030176320 For therapy of cancer, autoimmune diseases and restenosis; efficiency
09/18/2003US20030176303 Novel detergent compositions with enhanced depositing, conditioning and softness capabilities
09/18/2003US20030175996 Peptide fructose and complex thereof with binding protein
09/18/2003US20030175930 Crystals of LuxP and complexes thereof
09/18/2003US20030175921 Complexing antigen, antibodies; immunoassay
09/18/2003US20030175849 Identifying compounds for treating vision defects associated with intraocular pressure
09/18/2003US20030175822 Opiate, cannabinoid, and estrogen receptors
09/18/2003US20030175745 Peptides with growth inhibitory action
09/18/2003US20030175731 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies
09/18/2003US20030175711 Comprises ordered and repetitive antigen or antigenic determinant array for developing vaccines for treatment of infectious diseases, allergies and cancer; microarrays
09/18/2003US20030175370 Dry mixture of carbohydrates and drugs; wound healing agents
09/18/2003US20030175357 Prolonged anesthesia in joints and body spaces
09/18/2003US20030175356 Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma
09/18/2003US20030175355 Fast melt multiparticulate formulations for oral delivery
09/18/2003US20030175354 Antiemetic, anti-motion sustained release drug delivery system
09/18/2003US20030175352 Having a plurality of solid, polymeric matrix beads comprising considerable amounts of greasy/oily/sticky substances and having fast release characteristics; drug delivery
09/18/2003US20030175351 Pharmaceutical composition for oral use with improved absorption
09/18/2003US20030175346 Comprises a single-layer compressed core containing drug surrounded by a water permeable layer having a passageway, hydroxyethylcellulose, and osmagent
09/18/2003US20030175343 Controlled release pharmaceutical composition containing tramadol hydrochloride
09/18/2003US20030175338 Formulations of atorvastatin stabilized with alkali metal additions
09/18/2003US20030175335 Pectin film compositions
09/18/2003US20030175334 Phospholipid bodies and use thereof in medical treatment
09/18/2003US20030175333 Invisible patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients onto the skin
09/18/2003US20030175331 Pressure sensitive adhesive comprising isoprene-styrene block copolymer/tackifier resin and diclofenac sodium
09/18/2003US20030175330 Transdermal therapeutical system with a reduced tendency of the active substance to crystallize
09/18/2003US20030175329 Semisolid topical hormonal compositions and methods for treatment
09/18/2003US20030175328 Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin
1 ... 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 ... 1712